膽囊癌市場：依治療類型、按癌症類型、按配銷通路、按地區

全球膽囊癌市場規模預計將從 2023 年的 7,350 萬美元增至 2030 年的 1.001 億美元，預測期內年複合成長率為 4.5%。

圖 1. 2023 年膽囊癌的全球市場佔有率（按地區分類）

膽囊癌是一種相對罕見的癌症，多發生於老年女性。膽囊癌通常在晚期才被發現，此時已無法透過手術切除膽囊。膽囊是一個梨形的小器官，位於腹部右側，肝臟下方。膽囊儲存膽汁，膽汁是肝臟分泌的消化液。膽囊癌的危險因子包括膽結石、膽囊息肉、慢性膽囊炎和某些遺傳性疾病。膽囊癌的症狀包括腹痛（尤其是右上象限疼痛）、腹脹、發燒、體重意外減輕、噁心以及皮膚或眼白發黃（黃疸）。

市場動態：

膽囊癌治療的全球市場預計在未來幾年將顯著成長。膽囊癌發生率的上升（主要在新興市場）是市場成長的主要動力。此外，診斷技術和治療方法的進步正在提高患者的生存率和生活品質。例如，根據美國癌症協會發表的資料，2023年將新增12,220例膽囊癌病例，其中男性5,750例，女性6,470總合。

本研究的主要特點

• 該報告對全球膽囊癌市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
• 它還闡明了不同細分市場的潛在收益成長機會，並解釋了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球膽囊癌市場的主要企業。
• 研究涵蓋的主要企業包括禮來公司、百時美施貴寶、羅氏、輝瑞、諾華、默克公司、賽諾菲、阿斯特捷利康、艾伯維和吉利德科學。
• 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 全球膽囊癌市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過分析全球膽囊癌市場時所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 膽囊癌市場－冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 膽囊癌市場，依治療類型，2018-2030

• 介紹
• 外科手術
• 化療
• 放射治療
• 免疫療法
• 標靶治療
• 其他

第6章 2018-2030 年膽囊癌市場（按癌症類型）

• 介紹
• 腺癌
• 鱗狀細胞癌
• 腺鱗癌
• 小細胞癌
• 其他

第7章 膽囊癌市場，依配銷通路分類，2018-2030

• 介紹
• 醫院藥房
• 零售藥房
• 線上藥房
• 其他

第8章 2018-2030 年膽囊癌市場（按地區）

• 介紹
• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 韓國
• 東南亞國協
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第9章 競爭形勢

• Eli Lilly and Company
• Bristol-Myers Squibb
• Roche
• Pfizer
• Novartis
• Merck & Co., Inc.
• Sanofi
• AstraZeneca
• AbbVie
• Gilead Sciences

第10章 章

• 調查方法
• 關於出版商

The global gallbladder cancer market size is projected to reach US$ 100.1 million by 2030, from US$ 73.5 million in 2023, at a CAGR of 4.5% during the forecast period.

Figure 1. Global Gallbladder Cancer Market Share (%), By Region, 2023

Gallbladder cancer is a relatively rare cancer that is most common in older women. It is often discovered at its late stage, when it is no longer possible to remove the gallbladder surgically. The gallbladder is a small, pear-shaped organ on the right side of the abdomen, just beneath the liver. The gallbladder stores bile, a digestive fluid produced by liver. Risk factors for gallbladder cancer include gallstones, gallbladder polyps, chronic gallbladder inflammation, and certain inherited conditions. Symptoms of gallbladder cancer may include abdominal pain, particularly in the upper right portion of the abdomen, abdominal bloating, fever, unintended weight loss, nausea, and yellowing of the skin and the whites of the eyes (jaundice).

Market Dynamics:

The global market for gallbladder cancer treatment is expected to witness significant growth in the coming years. The rising incidence of gallbladder cancer, primarily in developing countries, is a major driver for market growth. Additionally, advancements in diagnostic techniques and treatment modalities are enhancing the survival rates and quality of life for patients. For instance, according to the data published by the American Cancer Society in , about 12,220 new cases of gallbladder cancer : 5,750 in men and 6,470 in women in 2023.

Key features of the study:

• This report provides an in-depth analysis of the global gallbladder cancer market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gallbladder cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gallbladder cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gallbladder cancer market

Detailed Segmentation:

• By Treatment Type
  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Targeted Therapy
  • Others
• By Cancer Type
  • Adenocarcinoma
  • Squamous cell carcinoma
  • Adenosquamous carcinoma
  • Small cell carcinoma
  • Undifferentiated carcinoma
  • Others
• By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
• By Region
  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East
  • Africa
• Top Players Operating in Gallbladder Cancer Market
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Roche
  • Pfizer
  • Novartis
  • Merck & Co., Inc.
  • Sanofi
  • AstraZeneca
  • AbbVie
  • Gilead Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Gallbladder Cancer Market, By Treatment Type
  • Gallbladder Cancer Market, By Cancer Type
  • Gallbladder Cancer Market, By Distribution Channel
  • Gallbladder Cancer Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of gallbladder cancer
  • High cost burden of cancer therapies
  • Development of targeted therapies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Gallbladder Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Gallbladder Cancer Market, By Treatment Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Radiation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Gallbladder Cancer Market, By Cancer Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Adenocarcinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Squamous cell carcinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Adenosquamous carcinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Small cell carcinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Gallbladder Cancer Market, By Distribution Channel, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Gallbladder Cancer Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 - 2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• Japan
• India
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030, (US$ Mn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Roche
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AbbVie
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Gilead Sciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us